Reach Us +441902928240
Tamer Elbayoumi | OMICS International
ISSN: 2155-9589

Journal of Membrane Science & Technology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Tamer Elbayoumi

Tamer Elbayoumi Department of Pharmaceutical Sciences
Midwestern University
College of Pharmacy-Glendale
Glendale, USA
Tel: (623) 572-3592
Fax: (623) 572-3565


Professor Tamer Elbayoumi BPharm MS Ph D has received his BS in Pharmacy from Alexandria University Alex Egypt and Master′s in Biomedical Sciences from Northeastern University Boston MA. He completed his Post Doctoral Fellowship at the Center of Pharmaceutical Biotechnology and Nanomedicine after receiving his PhD in Pharmaceutical Sciences from Northeastern University Boston MA in the period of 2003-2006. Before joining the faculty at Midwestern University Glendale as an assistant professor of Pharmaceutical Sciences he held the position of Senior Formulation Research Scientist R D Cardiology Systems at Atrium Medical Corp Hudson NH, where he was responsible for development of drug eluting implants at various clinical phases In addition to serving as a peerreviewer for numerous reputed scientific research journals like journal of controlled release journal of liposome research. Langmuir Dr Elbayoumi has published over 25 research papers review articles and book chapters mostly in the area of targeted nanocarrier delivery systems for therapeutics and imaging agents as well as being a graduate member of the pharmaceutical Rho Chi Honor Society he was a recipient of the international “Outstanding Parenteral Drug Delivery Award” of the Controlled Release Society in Vienna Austria.

Research Interest

His research areas of interest include development of nano-pharmaceutical formulations for investigational cardiovascular therapy, cancer chemotherapy and diagnostic imaging.

Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7